Company Overview and News
SaleBhai Internet Ltd, owner and operator of e-commerce marketplace SaleBhai.com, has become the first B2C e-commerce company to have filed a draft prospectus with the SME platform of BSE Ltd.
Ahmedabad-based GSEC Aviation and Monarch Networth Capital have bought over the G R Gopinath-promoted Air Deccan, besides jointly acquiring majority stake in Air Odisha, which is set to launch its services on regional routes from Saturday. Significantly, GSEC Aviation is owned by Rakesh Ramanlal Shah, who is married to Prity, the sister of the $11 billion Adani Group Chairman Gautam Adani. Under the new structure, both the airlines would be owned by a new company called GSEC Monarch Aviation, in which Air Deccan would hold 50 per cent stake, while the rest would be held by GSEC Aviation and Monarch Networth.
The Ahmedabad-based GSEC Aviation and Monarch Networth Capital have bought over the GR Gopinath-promoted Air Deccan, besides jointly acquiring majority stake in Air Odisha, which is set to launch its services on regional routes from tomorrow.
Mumbai : India’s first low-cost carrier Air Deccan, which ceased operations after being acquired by erstwhile Kingfisher Airlines in 2008, took off wings again as a commuter airline with its maiden flight taking off for Jalgaon from here on Saturday.
India's first low-cost carrier Air Deccan, which ceased operations after being acquired by erstwhile Kingfisher Airlines in 2008, took off wings again as a commuter airline with its maiden flight taking off for Jalgaon from here today.
Mumbai: India’s first low-cost carrier Air Deccan, which ceased operations after being acquired by erstwhile Kingfisher Airlines in 2008, had its maiden run on Saturday with a UDAN flight from Mumbai to Jalgaon.
The Gujarat polls are telling on the financial fortunes of investors in State-run public enterprises, which have reported a slide in their prices in the range of 3-18 per cent over the past one month.
A host of companies including Alkyl Amines Chemicals, Bedmutha Industries, Esteem Bio Organic Food Processing, Kesar Terminal & Infrastructure, Manugraph India, Mohit Paper, Monarch Networth Capital, Monsanto India, Perfactpac, Revathi Equipment, Siemens, Skipper, Star Paper Mills and Sunil Healthcare will announce their quarterly numbers for the period ended September 2017 on Thursday. Focus will be on the performance of Siemens and Skipper.
Migration of Equity Shares of VCU Data Management Limited from BSE SME Platform to BSE Mainboard Platform
HPCL | NTPC | Sun TV Network | Oberoi Realty | Claris Life | Dilip Buildcon | Alankit | IL&FS Engineering | ARSS Infra | Elecon Engineering | Ujjivan | Welspun India | DCW | Gujarat Alkalies and Grasim Industries are stocks, which are in the news today.
Quess Corp, a Bengaluru-based staffing firm, is going to hit the capital market on Wednesday with initial public offering (IPO) of 1,29,03,226 shares of Rs 10 each in a price band Rs 310-317 per equity share. The issue will open for subscription on June 29, 2016 and will close on July 1, 2016. At present, Thomas Cook India is the corporate promoter of the company holding 70 per cent shares of the company.
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.
Small and medium enterprise (SME) platforms of both BSE and NSE have opened doors for regional merchant bankers. Cashing in on the trend of SMEs raising capital through such platforms, regional merchant bankers have joined the bandwagon by offering services similar to national level merchant bankers for listing SMEs on platforms.
6m - Asif
Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...